APTEVO THERAPEUTICS INC (APVO) Stock Analyst Earnings Estimates
NASDAQ:APVO - Nasdaq - US03835L3069 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.309M | 12.292M 185.26% | 3.114M -74.67% | -100.00% | 6.871M | 18.091M 163.30% | 31.032M 71.53% | 41.455M 33.59% | 49.57M 19.58% | 56.04M 13.05% | ||||
| EBITDA YoY % growth | -26.088M 32.64% | -20.256M 22.36% | -27.74M -36.95% | N/A -2.06% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.494M 32.88% | -21.4M 22.16% | -28.641M -33.84% | -29.808M -0.83% | -23.907M 17.21% | -21.342M 10.73% | -21.685M -1.61% | 37.065M 270.92% | -4.296M -111.59% | 8.831M 305.55% | 19.433M 120.05% | 27.723M 42.66% | 34.36M 23.94% | |
| Operating Margin | -638.06% | -174.10% | -919.75% | N/A | N/A | N/A | N/A | 539.44% | -23.75% | 28.46% | 46.88% | 55.93% | 61.31% | |
| EPS YoY % growth | -394.24 43.86% | -267.96 32.03% | 69.52 125.94% | -2,847.86 -193.67% | -87.68 -34.64% | -16.16 81.57% | -14.78 8.52% | -10.23 30.78% | -2.49 75.67% | 1.99 179.92% | 4.28 115.38% | 4.72 10.24% | 5.98 26.57% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -7.91 -28.33% | -4.00 98.91% | -3.97 93.58% | -3.61 79.67% | -3.58 54.71% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.322M 16.63% | -5.327M 23.71% | -5.333M 11.48% | -5.339M 13.54% | -5.344M -0.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -17.76 19.27% | -126.62 | 108.86 | 85.97% |
| Q2 2024 Q2Q % growth | -61.79 -14.17% | -247.20 | 185.41 | 75.00% |
| Q1 2024 Q2Q % growth | -368.15 -2,245.40% | -484.77 | 116.62 | 24.06% |
| Q4 2023 Q2Q % growth | -6.16 85.26% | -18.40 | 12.24 | 66.52% |
| Q3 2023 Q2Q % growth | -22.00 66.67% | -33.66 | 11.66 | 34.64% |
| Q2 2023 Q2Q % growth | -54.12 -122.04% | -50.27 | -3.85 | -7.67% |
| Q1 2023 Q2Q % growth | 17.16 125.16% | -53.18 | 70.34 | 132.27% |
| Q4 2022 Q2Q % growth | -41.80 25.20% | -68.67 | 26.87 | 39.13% |
| Q3 2022 Q2Q % growth | -66.00 -4.90% | -73.60 | 7.60 | 10.33% |
| Q2 2022 Q2Q % growth | 245.52 418.86% | -59.69 | 305.21 | 511.32% |
| Q1 2022 Q2Q % growth | -68.20 5.49% | -51.61 | -16.59 | -32.14% |
| Q4 2021 Q2Q % growth | -55.88 33.85% | -58.12 | 2.24 | 3.85% |
| Q3 2021 Q2Q % growth | -62.92 31.90% | -66.20 | 3.28 | 4.95% |
| Q2 2021 Q2Q % growth | -77.00 16.67% | -89.76 | 12.76 | 14.22% |
| Q1 2021 Q2Q % growth | -72.16 42.25% | 75.85 | -148.01 | -195.14% |
| Q4 2020 Q2Q % growth | -84.48 19.33% | -54.53 | -29.95 | -54.93% |
| Q3 2020 Q2Q % growth | -92.40 34.78% | -90.43 | -1.97 | -2.17% |
| Q2 2020 Q2Q % growth | -92.40 50.00% | -92.23 | -0.17 | -0.19% |
| Q1 2020 Q2Q % growth | -124.96 53.90% | -105.47 | -19.49 | -18.48% |
| Q4 2019 Q2Q % growth | -104.72 | -161.27 | 56.55 | 35.07% |
| Q3 2019 Q2Q % growth | -141.68 | -150.80 | 9.12 | 6.05% |
| Q2 2019 Q2Q % growth | -184.80 | -207.35 | 22.55 | 10.87% |
| Q1 2019 Q2Q % growth | -271.04 | -276.46 | 5.42 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 3.494M | -3.494M | -100.00% |
| Q1 2022 Q2Q % growth | 3.114M 28.62% | 3.825M | -711K | -18.59% |
| Q4 2021 Q2Q % growth | 3.665M 54.45% | 3.468M | 197K | 5.68% |
| Q3 2021 Q2Q % growth | 3.096M 111.62% | 3.723M | -627K | -16.84% |
| Q2 2021 Q2Q % growth | 3.11M 557.51% | 918K | 2.192M | 238.78% |
| Q1 2021 Q2Q % growth | 2.421M | 13.328M | -10.907M | -81.84% |
| Q4 2020 Q2Q % growth | 2.373M | 1.78M | 593K | 33.31% |
| Q3 2020 Q2Q % growth | 1.463M | 574.943K | 888.057K | 154.46% |
| Q2 2020 Q2Q % growth | 473K | 266.903K | 206.097K | 77.22% |
| Q1 2020 Q2Q % growth | 5.272M | -5.272M | -100.00% | |
| Q4 2019 Q2Q % growth | 9.609M | -9.609M | -100.00% | |
| Q3 2019 Q2Q % growth | 9.18M | -9.18M | -100.00% | |
| Q2 2019 Q2Q % growth | 7.185M | -7.185M | -100.00% | |
| Q1 2019 Q2Q % growth | 6.903M | -6.903M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3600% | -3600% | 86.44% | -398.75% |
| Revenue | N/A | N/A | N/A | N/A |